|
2022, Volume 38, Number 2, Page(s) 142-147
|
|
DOI: 10.5146/tjpath.2021.01540 |
HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case |
Göksenil BÜLBÜL1, Gülen GÜL2, Mehmet Ali ÖZCAN3, Sermin ÖZKAL1 |
1Department of Pathology, Dokuz Eylül University, School of Medicine, IZMIR, TURKEY 2University of Health Sciences, Tepecik Training and Research Hospital, IZMIR, TURKEY 3Department of Hematology, Dokuz Eylul University, School of Medicine, IZMIR, TURKEY |
Keywords:
Castleman disease, Germinotropic lymphoproliferative disorder, EBV, HHV-8 |
Human herpes virus-8 (HHV-8) is linked to four lymphoproliferative diseases: primary effusion lymphoma, HHV-8 positive multicentric
Castleman disease (MCD), HHV-8 positive diffuse large B cell lymphoma and HHV-8 positive germinotropic lymphoproliferative disorder
(GLPD). The diagnosis of HHV-8 associated lymphoproliferative diseases is quite challenging because each entity is rare and has a wide
morphological spectrum. Our aim is to emphasize the overlapping histopathological features of MCD and GLPD as well as to underline the
importance of clinicopathological correlation in case these two entities cannot be distinguished by pathological examination.
We present here a case of an 82-year-old male patient who was examined for weight loss and multiple lymphadenopathy. Histopathological
examination of the axillary lymph node revealed lymphoid follicle structures of varying shapes and sizes, including some atrophic germinal
centers. Plasmablast-like cells were notable in some of these areas. HHV-8 and Epstein Barr Virus (EBV) positivity were noted in some of these
cells and in a small number of cells in the mantle zone. Based on these findings; a diagnosis of HHV-8 and EBV positive lymphoproliferative
disease was established.
Since HHV-8 positive MCD and GLPD have similar histopathological features, it may not be possible to distinguish these two entities by
histopathological examination only. At this point, the importance of clinicopathological correlation becomes more evident, especially in the
determination of the treatment protocol to be applied to the patient.
|
|
|
|